Oramed Pharmaceuticals (NASDAQ:ORMP) Stock Price Crosses Above 50 Day Moving Average – Time to Sell?
Oramed Pharmaceuticals Inc. (NASDAQ:ORMP – Get Free Report)’s share price passed above its 50 day moving average during trading on Thursday . The stock has a 50 day moving average of $2.37 and traded as high as $2.49. Oramed Pharmaceuticals shares last traded at $2.49, with a volume of 158,176 shares traded. Analyst Ratings Changes […]
More Stories
PennyMac Mortgage Investment Trust (NYSE:PMT) to Issue $0.40 Quarterly Dividend
PennyMac Mortgage Investment Trust (NYSE:PMT – Get Free Report) announced a quarterly dividend on Friday, December 13th,NASDAQ Dividends reports. Investors...
2x Ether ETF Declares Dividend of $0.00 (NYSEARCA:ETHU)
2x Ether ETF (NYSEARCA:ETHU – Get Free Report) announced a dividend on Friday, December 13th,NASDAQ Dividends reports. Investors of record...
Reviewing PAVmed (NASDAQ:PAVM) & PolyPid (NASDAQ:PYPD)
PAVmed (NASDAQ:PAVM – Get Free Report) and PolyPid (NASDAQ:PYPD – Get Free Report) are both small-cap medical companies, but which...
Themes Robotics & Automation ETF (NASDAQ:BOTT) Short Interest Update
Themes Robotics & Automation ETF (NASDAQ:BOTT – Get Free Report) was the recipient of a significant decline in short interest...
Brookline Bancorp, Inc. (NASDAQ:BRKL) Short Interest Update
Brookline Bancorp, Inc. (NASDAQ:BRKL – Get Free Report) saw a significant growth in short interest in the month of November....
iShares Transition-Enabling Metals ETF (NASDAQ:TMET) Short Interest Update
iShares Transition-Enabling Metals ETF (NASDAQ:TMET – Get Free Report) saw a significant drop in short interest in the month of...